SG11202104378SA - Methods of treating rett syndrome using fenfluramine - Google Patents
Methods of treating rett syndrome using fenfluramineInfo
- Publication number
- SG11202104378SA SG11202104378SA SG11202104378SA SG11202104378SA SG11202104378SA SG 11202104378S A SG11202104378S A SG 11202104378SA SG 11202104378S A SG11202104378S A SG 11202104378SA SG 11202104378S A SG11202104378S A SG 11202104378SA SG 11202104378S A SG11202104378S A SG 11202104378SA
- Authority
- SG
- Singapore
- Prior art keywords
- fenfluramine
- methods
- rett syndrome
- treating rett
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862769441P | 2018-11-19 | 2018-11-19 | |
| PCT/IB2019/060067 WO2020105005A1 (en) | 2018-11-19 | 2019-11-22 | Methods of treating rett syndrome using fenfluramine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202104378SA true SG11202104378SA (en) | 2021-05-28 |
Family
ID=68808446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202104378SA SG11202104378SA (en) | 2018-11-19 | 2019-11-22 | Methods of treating rett syndrome using fenfluramine |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220008389A1 (en) |
| EP (1) | EP3883555A1 (en) |
| AU (2) | AU2019384963B2 (en) |
| CA (1) | CA3117868A1 (en) |
| EA (1) | EA202191079A1 (en) |
| SG (1) | SG11202104378SA (en) |
| WO (1) | WO2020105005A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3007673A1 (en) | 2015-12-22 | 2017-06-29 | Zogenix International Limited | Metabolism resistant fenfluramine analogs and methods of using the same |
| BR112018011777A2 (en) | 2015-12-22 | 2018-12-04 | Zogenix International Ltd | fenfluramine compositions and methods for preparing them |
| JP2019526544A (en) | 2016-08-24 | 2019-09-19 | ゾゲニクス インターナショナル リミテッド | Formulations for inhibiting the formation of 5-HT2B agonists and methods of use thereof |
| US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
| EP3790537A1 (en) | 2018-05-11 | 2021-03-17 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
| US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| GB2597314A (en) * | 2020-07-20 | 2022-01-26 | Gw Res Ltd | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities |
| GB2597321A (en) * | 2020-07-20 | 2022-01-26 | Gw Res Ltd | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1413070A (en) | 1973-07-27 | 1975-11-05 | Beecham Group Ltd | Process for the production of - norfenfluramine and - fenfluramine and salts thereof |
| GB1413078A (en) | 1973-07-27 | 1975-11-05 | Beecham Group Ltd | Process for the production of plus-norfenfluramine and plus-fenfluramine and salts thereof |
| IT1238686B (en) | 1990-02-09 | 1993-09-01 | Lab Mag Spa | PROCEDURE FOR THE PREPARATION OF LEVO AND RIGHT FENFLURAMINA |
| WO2010020585A1 (en) * | 2008-08-18 | 2010-02-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin reuptake inhibitors for the treatment of rett syndrome |
| CN107868071B (en) | 2012-11-05 | 2021-07-20 | 爱默蕾大学 | 7, 8-dihydroxyflavone and 7, 8-substituted flavone derivatives, compositions, and methods related thereto |
| WO2017035267A1 (en) * | 2015-08-24 | 2017-03-02 | Zogenix International Limited | Methods of treating lennox-gastaut syndrome using fenfluramine |
| BR112018011777A2 (en) | 2015-12-22 | 2018-12-04 | Zogenix International Ltd | fenfluramine compositions and methods for preparing them |
| US20180092864A1 (en) | 2016-09-30 | 2018-04-05 | Zogenix International Limited | Compositions and methods for treating seizure disorders |
| EP3790537A1 (en) * | 2018-05-11 | 2021-03-17 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
-
2019
- 2019-11-22 EP EP19816891.6A patent/EP3883555A1/en active Pending
- 2019-11-22 AU AU2019384963A patent/AU2019384963B2/en active Active
- 2019-11-22 WO PCT/IB2019/060067 patent/WO2020105005A1/en unknown
- 2019-11-22 SG SG11202104378SA patent/SG11202104378SA/en unknown
- 2019-11-22 CA CA3117868A patent/CA3117868A1/en active Pending
- 2019-11-22 EA EA202191079A patent/EA202191079A1/en unknown
- 2019-11-22 US US17/289,125 patent/US20220008389A1/en active Pending
-
2022
- 2022-08-24 AU AU2022221450A patent/AU2022221450B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022221450A1 (en) | 2022-09-22 |
| AU2019384963B2 (en) | 2022-05-26 |
| AU2022221450B2 (en) | 2024-04-11 |
| EP3883555A1 (en) | 2021-09-29 |
| AU2019384963A1 (en) | 2021-06-10 |
| CA3117868A1 (en) | 2020-05-28 |
| US20220008389A1 (en) | 2022-01-13 |
| WO2020105005A1 (en) | 2020-05-28 |
| EA202191079A1 (en) | 2021-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202104378SA (en) | Methods of treating rett syndrome using fenfluramine | |
| IL257276B (en) | Methods of treating lennox-gastaut syndrome using fenfluramine | |
| ZA201907168B (en) | Methods of treating doose syndrome using fenfluramine | |
| SG11202010830WA (en) | Methods of treating phenylketonuria | |
| EP3579833A4 (en) | Methods of treating influenza | |
| EP3846796A4 (en) | Methods of treating cytokine release syndrome | |
| EP3813808A4 (en) | Methods of treating substance abuse | |
| EP3813806A4 (en) | Methods of treating mitochondrial dysfunction | |
| EP3883580A4 (en) | Methods of treating cancers | |
| IL265342A (en) | Use of pridopidine for treating rett syndrome | |
| EP3773633A4 (en) | Methods of treating glioblastomas | |
| EP3478281A4 (en) | Methods of treating prader-willi syndrome | |
| EP3703669A4 (en) | Methods of treating cancers | |
| EP3634422A4 (en) | Methods of treating leukodystrophies | |
| EP3886867A4 (en) | Methods of treating whsc1-overexpressing cancers by inhibiting setd2 | |
| EP3894768C0 (en) | Methods of cryo-curing | |
| EP3600550A4 (en) | Methods of treating melanoma | |
| EP3784231A4 (en) | Methods of treating hypertension | |
| IL288353A (en) | Methods of treating cholangiocarcinoma | |
| EP3420082A4 (en) | Methods of treating intestinal fibrosis using smad7 inhibition | |
| IL283054A (en) | Methods of treating myelodysplastic syndrome | |
| EP3897642A4 (en) | Methods of treating inflammation | |
| IL262547A (en) | Methods and compositions for treatment of rett syndrome | |
| IL290983A (en) | Methods of treatment | |
| AU2018904884A0 (en) | Methods of treating inflammation |